Literature DB >> 19896065

Longitudinal assessment of colonic tumor fate in mice by computed tomography and optical colonoscopy.

Benjamin Y Durkee1, Kazuhiko Shinki, Michael A Newton, Caitlin E Iverson, Jamey P Weichert, William F Dove, Richard B Halberg.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of this study was to evaluate the relative merits of micro-computed tomograph colonography (mCTC) and optical colonoscopy (OC) for longitudinal studies of colonic tumors in mice.
MATERIALS AND METHODS: Colonic tumors in mice carrying the Min allele of Apc were followed over several weeks using mCTC and OC. A total of 146 colonic tumors were monitored: 62 in 32 untreated Min mice, 53 in 43 Min mice treated with 5-fluorouracil (5-FU), and 31 in 17 Min mice treated with piroxicam.
RESULTS: Colonic tumors in Min mice had three different spontaneous fates: 29 grew, 24 remained static, and 9 regressed. Treating Min mice with 5-FU increased the percentage of regressing tumors from 15% to 58%. The response was dependent in part on the initial size of the tumor. By contrast, treating Min mice with piroxicam did not alter colonic tumor fate.
CONCLUSIONS: mCTC and OC can be used to determine the spontaneous fates of colonic tumors in mice and to document their individual responses to treatment. The ability to follow individually annotated colonic tumors reduces the number of mice needed for testing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896065      PMCID: PMC2818525          DOI: 10.1016/j.acra.2009.07.023

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  26 in total

1.  The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis.

Authors:  H S Cooper; L Everley; W C Chang; G Pfeiffer; B Lee; S Murthy; M L Clapper
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

2.  Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.

Authors:  R F Jacoby; C E Cole; K Tutsch; M A Newton; G Kelloff; E T Hawk; R A Lubet
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

3.  Detection and volume determination of colonic tumors in Min mice by magnetic resonance micro-imaging.

Authors:  Harvey H Hensley; Wen-Chi Chang; Margie L Clapper
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

4.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

Authors:  A R Moser; H C Pitot; W F Dove
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

Review 5.  Counterpoint: From animal models to prevention of colon cancer. Criteria for proceeding from preclinical studies and choice of models for prevention studies.

Authors:  W Robert Bruce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

Review 6.  Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.

Authors:  Denis E Corpet; Fabrice Pierre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

7.  Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice.

Authors:  Jody M Tucker; Celestia Davis; Maria E Kitchens; Marlene A Bunni; David G Priest; H Trent Spencer; Franklin G Berger
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.

Authors:  P Thirion; S Michiels; J P Pignon; M Buyse; A C Braud; R W Carlson; M O'Connell; P Sargent; P Piedbois
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

10.  Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway.

Authors:  Richard B Halberg; Jesse Waggoner; Kristen Rasmussen; Alanna White; Linda Clipson; Amy J Prunuske; Jeffery W Bacher; Ruth Sullivan; Mary Kay Washington; Henry C Pitot; John H J Petrini; Donna G Albertson; William F Dove
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

View more
  9 in total

1.  The many ways to open the gate to colon cancer.

Authors:  James M Amos-Landgraf; Linda Clipson; Michael A Newton; William F Dove
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

2.  A simple, quantitative method using alginate gel to determine rat colonic tumor volume in vivo.

Authors:  Amy A Irving; Lindsay B Young; Jennifer K Pleiman; Michael J Konrath; Blake Marzella; Michael Nonte; Justin Cacciatore; Madeline R Ford; Linda Clipson; James M Amos-Landgraf; William F Dove
Journal:  Comp Med       Date:  2014-04       Impact factor: 0.982

3.  Dual optical modality endoscopic imaging of cancer development in the mouse colon.

Authors:  Molly R Keenan; Sarah J Leung; Photini S Rice; R Andrew Wall; Jennifer K Barton
Journal:  Lasers Surg Med       Date:  2014-12-01       Impact factor: 4.025

4.  Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models.

Authors:  Amy A Irving; Richard B Halberg; Dawn M Albrecht; Lori A Plum; Kathleen J Krentz; Linda Clipson; Norman Drinkwater; James M Amos-Landgraf; William F Dove; Hector F DeLuca
Journal:  Arch Biochem Biophys       Date:  2011-09-01       Impact factor: 4.013

5.  Double-contrast micro-CT colonoscopy in live mice.

Authors:  Hanne Boll; Simona Bag; Ingo S Nölte; Thomas Wilhelm; Martin Kramer; Christoph Groden; Ulrich Böcker; Marc A Brockmann
Journal:  Int J Colorectal Dis       Date:  2011-03-25       Impact factor: 2.571

6.  Colonoscopy as a tool for evaluating colorectal tumor development in a mouse model.

Authors:  Tomohiro Adachi; Takao Hinoi; Yuu Sasaki; Hiroaki Niitsu; Yasuhumi Saito; Masashi Miguchi; Manabu Shimomura; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2013-11-09       Impact factor: 2.571

7.  Multimodal imaging of growth and rapamycin-induced regression of colonic adenomas in apc mutation-dependent mouse.

Authors:  Sharon J Miller; Kevin A Heist; Ying Feng; Craig J Galbán; Alnawaz Rehemtulla; Brian D Ross; Eric R Fearon; Thomas D Wang
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

8.  Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.

Authors:  Jamie N Hadac; Devon D Miller; Ian C Grimes; Linda Clipson; Michael A Newton; William R Schelman; Richard B Halberg
Journal:  Anticancer Res       Date:  2016-03       Impact factor: 2.480

9.  Dynamic tumor growth patterns in a novel murine model of colorectal cancer.

Authors:  Terrah J Paul Olson; Jamie N Hadac; Chelsie K Sievers; Alyssa A Leystra; Dustin A Deming; Christopher D Zahm; Dawn M Albrecht; Alice Nomura; Laura A Nettekoven; Lauren K Plesh; Linda Clipson; Ruth Sullivan; Michael A Newton; William R Schelman; Richard B Halberg
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.